Drugs / mRNA-1283.251
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07089706 | Jul 2025 → Jun 2026 | COVID-19 | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1283.251 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07089706 ↗ |